• Whole Exome Sequence Analysis, NGS
  • CDH1 Gene Mutation Analysis
  • Hepatitis B Virus (HBV) by Molecular Method, Qualitative
  • B-cell Activating Factor Receptor (BAFF-R) Gene Mutation Analysis
  • Magnesium, Serum
  • Macroprolactin, Serum
  • Bacterial Culture, Blood
  • Biopsy, Kidney
  • Insulin-Like Growth Factor I (IGF1)
  • Williams Syndrome, 7q11.23 Deletion, FISH, Tissue
  • LDS
  • Sign up
  • Log in
  • LDS
  • /Medical Tests
  • /Prolyl Hydroxylase Domain-2 (PHD2/EGLN1) Gene Mutation Analysis
  • All
  • Diseases
  • Overview
  • Clinical Utility
  • Interpretation
  • Reference Ranges
  • Methodology
  • Specimen Collection
  • Additional Testing
  • Turnaround Time
  • CPT
  • ICD10
  • Additional ICD10
  • References
  • All
  • Diseases
  • Overview
  • Clinical Utility
  • Interpretation
  • Reference Ranges
  • Methodology
  • Specimen Collection
  • Additional Testing
  • Turnaround Time
  • CPT
  • ICD10
  • Additional ICD10
  • References

Prolyl Hydroxylase Domain-2 (PHD2/EGLN1) Gene Mutation Analysis
Medical Test

Interpretation
Access to Prolyl Hydroxylase Domain-2 (PHD2/EGLN1) Gene Mutation Analysis is restricted.